A company is developing a new drug for treatment for a fatal human disease . They have successfully tested vitro on animals . Results indicated that there is no harmful and is more effective for any other drug than currently. Clinical tested diseases with humans are being planned, using double-blind experiment placebo. Which of the following is the best ethical issue at this type of research.